IGF1 and ocular melanoma: GH peak to ITT showed a significant positive correlation with IGF-1 SDS in the entire cohort (ρ = 0.70, P < .001), in OS-GHD (ρ = 0.89, P < .001), and in OM-GHD (ρ = 0.54, P < .001) groups, even after excluding female patients who were receiving HRT (data not shown).